Dibash Kumar Das, PhD

A team of investigators conducted a comprehensive search of several databases to identify the prevalence of gastrointestinal symptoms in patients with COVID-19 infection.

Treatment considerations for vulnerable patients with pemphigus during the COVID-19 pandemic are outlined.

The delayed onset of a severe cutaneous reaction to hydroxychloroquine means clinicians may continue to see patients presenting with the symptoms.

Researchers showed that the management of symptoms in patients with COVID-19 pneumonia with upper GI bleeding was possible without endoscopy.